Tempus AI (NASDAQ:TEM) Sets New 12-Month High – Here’s What Happened

Tempus AI, Inc. (NASDAQ:TEM)’s share price hit a new 52-week high on Tuesday . The company traded as high as $79.02 and last traded at $77.79, with a volume of 334848 shares changing hands. The stock had previously closed at $77.62.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on TEM. Loop Capital raised their price objective on Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research report on Tuesday, October 15th. Needham & Company LLC reiterated a “buy” rating and issued a $47.00 price target on shares of Tempus AI in a research report on Wednesday, August 7th. Bank of America lowered Tempus AI from a “buy” rating to a “neutral” rating and lifted their price target for the stock from $45.00 to $60.00 in a research report on Wednesday, October 2nd. Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and lifted their price target for the stock from $45.00 to $65.00 in a research report on Monday. Finally, JPMorgan Chase & Co. lifted their price target on Tempus AI from $42.00 to $47.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $54.22.

Tempus AI Price Performance

The company has a quick ratio of 3.52, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The company’s 50-day simple moving average is $50.58.

Institutional Investors Weigh In On Tempus AI

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. First Horizon Advisors Inc. acquired a new stake in Tempus AI during the 3rd quarter worth about $30,000. Vestor Capital LLC acquired a new stake in Tempus AI during the 3rd quarter worth about $153,000. Sandia Investment Management LP acquired a new stake in Tempus AI during the 2nd quarter worth about $136,000. IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new stake in shares of Tempus AI during the 3rd quarter valued at about $258,000. Finally, Clarus Group Inc. acquired a new stake in shares of Tempus AI during the 3rd quarter valued at about $283,000.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.